Experts
    • Cardiovascular Disease
    • Internal Medicine
    • Interventional Cardiology
    • Advanced Techniques in Peripheral Intervention
    • Advanced Techniques in Cerebral Intervention
    • Advanced Techniques in Cardiac Intervention
    • Preventive Cardiology
    • Acute Coronary Syndrome
    Executive Director of Interventional Cardiovascular Programs, Brigham and Women’s Hospital Heart & Vascular Center
    Executive Director of Interventional Cardiovascular Programs, Brigham and Women’s Hospital Heart & Vascular Center
    Deepak L. Bhatt MD, MPH, FACC, FAHA, FSCAI, FESC, is Executive Director of Interventional Cardiovascular Programs at Brigham and Women’s Hospital Heart & Vascular Center and Professor of Medicine at Harvard Medical School. He is also a Senior Physician at Brigham and Women’s Hospital and a Senior Investigator in the TIMI Study Group. After graduating as valedictorian from the Boston Latin School, Dr. Bhatt obtained his undergraduate science degree as a National Merit Scholar at the Massachusetts Institute of Technology while also serving as a research associate at Harvard Medical School. He received his medical doctorate from Cornell University. He completed a Master in Public Health with a concentration in clinical effectiveness at Harvard University. His internship and residency in internal medicine were performed at the Hospital of the University of Pennsylvania, and his cardiovascular training was at Cleveland Clinic. He also completed fellowships in interventional cardiology and cerebral and peripheral vascular intervention as well as serving as Chief Interventional Fellow at Cleveland Clinic, where he spent several years as an interventional cardiologist and an Associate Professor of Medicine. He served for many years as Director of the Interventional Cardiology Fellowship and as Associate Director of the Cardiovascular Medicine Fellowship. He also served as Associate Director of the Cleveland Clinic Cardiovascular Coordinating Center. He was then recruited to be the Chief of Cardiology at VA Boston Healthcare System and served in that role for several years. Dr. Bhatt has been listed in Best Doctors in America from 2005 to 2016. He was selected by Brigham and Women’s Hospital as the 2014 Eugene Braunwald Scholar. Dr. Bhatt’s research interests include acute coronary syndromes, preventive cardiology, and advanced techniques in cardiac, cerebral, and peripheral intervention. He has authored or co-authored over 750 publications and is listed as a Thomson Reuters Highly Cited Researcher. He is the Editor of Cardiovascular Intervention: A Companion to Braunwald’s Heart Disease and Atherothrombosis in Clinical Practice published by Oxford University Press. He was the international PI for the CHARISMA and CRESCENDO trials and co-PI of the three CHAMPION trials. He served as chair of COGENT and helped lead STAMPEDE. He serves as co-chair of the REACH registry and chairs REDUCE-IT. He is co-PI of SAVOR-TIMI 53, SYMPLICITY HTN-3, and THEMIS. In 2014, he was listed in the AHA/ASA top ten advances in heart disease and stroke research (for STAMPEDE and SYMPLICITY HTN-3). He is the Chair of the AHA-GWTG Quality Oversight Committee. He is a Trustee of the ACC. He is Senior Associate Editor for News and Clinical Trials for ACC.org. He is the Editor of the peer-reviewed Journal of Invasive Cardiology, Chief Medical Editor of Cardiology Today’s Intervention for healthcare professionals, and Editor-in-Chief of the Harvard Heart Letter for patients.
    • Internal Medicine
    • Interventional Cardiology
    • Thromboembolism
    • Atrial Fibrillation
    Investigator, TIMI Study Group, Cardiovascular Division, Brigham and Women’s Hospital
    Investigator, TIMI Study Group, Cardiovascular Division, Brigham and Women’s Hospital
    Christian T. Ruff, MD, MPH is currently an Associate Physician in the Cardiovascular Division at Brigham and Women’s Hospital in Boston, MA and an Assistant Professor of Medicine at Harvard Medical School. Dr. Ruff graduated Magna Cum Laude from Harvard University with a degree in Neurobiology, earned his medical degree with Alpha Omega Alpha honors at the Johns Hopkins University School of Medicine, and his masters of public health at the Harvard School of Public Health. Dr. Ruff completed his internal medicine residency and cardiovascular medicine fellowship at the Brigham and Women’s Hospital. Dr. Ruff is an investigator in the Thrombolysis in Myocardial Infarction (TIMI) Study Group and serves the Director of the Pharmacogenetics Core Laboratory and the Assistant Director of the Clinical Events Committee. He has led a broad array of projects, ranging from investigator initiated studies of biomarkers and genetic variants to large clinical trials, including being the lead co-investigator for the ENGAGE AF-TIMI 48 study evaluating the factor Xa inhibitor edoxaban for the prevention of thromboembolism in patients with atrial fibrillation. Dr. Ruff has specific expertise in atrial fibrillation, both risk stratification and implementation of antithrombotic therapy for stroke prevention, as well as the treatment and prevention of venous thromboembolism. He has been selected to serve as the Chairman for the Stroke Prevention in Atrial Fibrillation Consensus Initiative for the North American Thrombosis Forum. He also has an interest in developing innovative computational and bioinformatic strategies to identify important relationships across genes, proteins, and compounds.
    • Critical Care Medicine
    • Internal Medicine
    • Pulmonary Disease
    • Thromboembolism
    • Professor of Medicine at Uniformed Services University of the Health Sciences
    Colonel Lisa K. Moores, MD, FCCP is the Associate Dean for Student Affairs and Professor of Medicine at the Uniformed Services University of the Health Sciences in Bethesda, Maryland. Dr. Moores graduated with a Bachelor of Arts degree from The Ohio State University in 1985. She received her medical degree from the Uniformed Services University in 1989 and then completed a residency in Internal Medicine and a fellowship in Pulmonary and Critical Care Medicine at Walter Reed Army Medical Center in Washington DC. Upon graduation from her fellowship, she was awarded the Outstanding Graduating Fellow Award and the Baily K. Ashford Award for Outstanding Clinical Research. She has completed over 25 years of active service in the United States Army Medical Corps. Assignments have included staff internist at Fort Belvoir Community Hospital, Assistant Chief of Critical Care at Walter Reed Army Medical Center, Associate Clerkship Director for USUHS Internal Medicine at Walter Reed Army Medical Center, and Assistant Dean for Clinical Sciences, USUHS. Throughout her career she has been awarded several teaching awards, including the Walter Reed Department of Medicine Outstanding Teacher, The Army Internal Medicine Master Teacher Award, the William P. Clements Award for Outstanding Military Educator and the American College of Chest Physicians’ Edward C. Rosenow Master Teacher Award. She holds the “A” Proficiency Designator and the Order of Military Medical Merit. Dr. Moores is board certified in Internal Medicine, Pulmonary Medicine, and Critical Care Medicine. She is a fellow of the American College of Physicians and the American College of Chest Physicians. She has over eighty invited presentations and over fifty published journal articles and book chapters which reflect her interests in venous thromboembolism, medical education, and adult learning.
    • Hematology and Oncology
    Executive Director, Thrombosis and Atherosclerosis Research Institute
    Executive Director, Thrombosis and Atherosclerosis Research Institute
    Dr. Weitz is a Professor of Medicine and Biochemistry and Biomedical Sciences at McMaster University and Executive Director of the Thrombosis and Atherosclerosis Research Institute. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Weitz now focuses his clinical work in the area of thrombosis. He holds an Endowed Chair in Cardiovascular Research at McMaster University, which is funded by the Heart and Stroke Foundation of Ontario. He also holds the Canada Research Chair (Tier 1) in Thrombosis. Dr. Weitz received the Medal in Medicine from the Royal College of Physicians and Surgeons of Canada in 1991, the Distinguished Scientist Award from the Heart and Stroke Foundation of Ontario in 1999, the Research Achievement Award from the Canadian Cardiovascular Society in 2006, the Jack Hirsh Award for Outstanding Academic Achievement from McMaster University in 2008, the Innovator Award from McMaster University in 2010, and the Special Recognition Award in Thrombosis from the American Heart Association in 2011. He is a member of the American Federation of Medical Research, the American Society for Clinical Investigation, and the Association of American Physicians, a Fellow of the American Heart Association, American and European Colleges of Cardiology, American College of Chest Physicians, and the Canadian Academy of Health Sciences. Dr. Weitz gave the Davidson Lecture at the University of Edinburgh in 2000, the Nossel Memorial Lecture at Columbia University in New York in 2003, and the Mosesson Lecture at the Blood Research Institute in Milwaukee in 2008. He directs a well-funded research laboratory that focuses on the biochemistry of blood coagulation and fibrinolysis as it applies to venous and arterial thrombosis. A former Vice-President of Research for the Heart and Stroke Foundation, member of the Board of Directors of the Heart and Stroke Foundation of Ontario, Chair of the Scientific Review Committee for the Heart and Stroke Foundation of Canada, member of the Executive Council on Thrombosis of the American Heart Foundation, and Chair of the Council on Vascular Biology for the American Society of Hematology, Dr. Weitz has published over 400 peer-reviewed papers and 54 textbook chapters.
    • Critical Care Medicine
    • Internal Medicine
    • Vascular Medicine
    Head of the Thrombosis Research Unit, Center for Vascular Medicine, University Hospital Dresden
    Head of the Thrombosis Research Unit, Center for Vascular Medicine, University Hospital Dresden
    • Assistant Professor, Internal Medicine and Vascular Medicine at Technical University Dresden
    Since 2007, Jan Beyer-Westendorf has been Deputy Head of the Division of Angiology, and in 2009 he became Head of the Thrombosis Research Unit at the Center for Vascular Medicine and Department of Medicine III, University Hospital “Carl Gustav Carus” Dresden, Germany. Prof. Beyer-Westendorf received his medical training, 1991–1998, at the University Hospitals “Carl-Gustav Carus” Dresden, the Charité in Berlin, Germany, and at Lincoln County Hospital Lincolnshire, UK. In 2005 he completed his residency in Internal Medicine at the University Hospitals “Carl-Gustav Carus” Dresden in the Department of Vascular Medicine and specialised in Intensive Care Medicine, Vascular Medicine and Haemostaseology up until 2009. His main research interests are venous thromboembolism, efficacy and safety of anticoagulant therapy and risk factors, management and outcome of bleeding complications during antithrombotic therapy. Prof. Beyer-Westendorf has served on the steering committees of numerous clinical trials in vascular medicine and participated as Principal Investigator in Phase III and Phase IV trials evaluating novel direct oral anticoagulants. Since 2011, he has been conducting a large regional prospective registry on the efficacy, safety and management aspects of oral anticoagulants in daily practice, which currently has over 2,700 patients enrolled. He has authored a number of well-received publications in peer-reviewed international journals as well as book chapters on different aspects of cardiovascular medicine. He also serves as reviewer for various international journals, such as The New England Journal of Medicine, The British Medical Journal, Blood, Lancet Hematology, Journal of Thrombosis and Haemostasis, Thrombosis and Haemostasis, and Thrombosis Research. In 2012, Professor Beyer-Westendorf received the venia legendi and serves as Privatdozent (Assistant Professor) of Internal Medicine and Vascular Medicine at the Medical Faculty of the Technical University Dresden, Germany. In 2014, he received the Max-Ratschow-Award, which is the most prestigious award of the German Vascular Society (DGA). Professor Beyer-Westendorf is married and proud father of three exhilarant kids.
    • Cardiovascular Disease
    • Professor of Cardiovascular Medicine at University of Birmingham
    Professor Lip, MD, is Professor of Cardiovascular Medicine at the University of Birmingham and is based in a busy city centre teaching hospital. He leads a large, multidisciplinary research group (including clinical and laboratory-based components) at the Centre for Cardiovascular Sciences, University of Birmingham, England. He is also Adjunct Professor of Cardiovascular Sciences, Aalborg University, Denmark; and Visiting Professor of Cardiology, Belgrade University, Serbia. Half of his time is spent as a clinical cardiologist, and he practises the full range of cardiovascular medicine, including outpatient clinics, with large atrial fibrillation and hypertension specialist clinics, and coronary care unit duties. He also undertakes coronary intervention and participates in a 24/7 primary angioplasty rota for ST elevation MIs. Professor Lip has had a major interest into the epidemiology of atrial fibrillation (AF), as well as the pathophysiology of thromboembolism in this arrhythmia. Furthermore, he has been researching stroke and bleeding risk factors, and improvements in clinical risk stratification. The CHA2DS2-VASc and HAS-BLED scores - for assessing stroke and bleeding risk, respectively – were first proposed and independently validated following his research, and are now incorporated into international guidelines. He was selected to the Thomson Reuters Science Watch list of ‘World’s Most Influential Scientific Minds 2014’, a ranking of today’s top 17 scholars who have published the greatest number of hot papers, ranked in the top 0.1% by citations, [issued June 2014; see website: http://sciencewatch.com/sites/sw/files/sw-article/media/worlds-most-influential-scientific-minds-2014.pdf]. In 2014, Professor Lip was ranked by Expertscape as one of the world's leading experts in the understanding and treatment of AF [http://www.prlog.org/12273752-expertscape-ranks-top-doctors-and-hospitals-in-atrial-fibrillation.html]. Professor Lip is a board member of the European Heart Rhythm Association (EHRA) and is Chairman of its scientific documents committee (2013-). He is also on the board of the ESC Acute Cardiac Care Association (ACCA, 2014-). Professor Lip was on the writing committee for the 8th American College of Chest Physicians (ACCP) Antithrombotic Therapy Guidelines for Atrial Fibrillation, as well as various guidelines and/or position statements from EHRA. He was also on the writing committees of the 2010 ESC Guidelines on Atrial Fibrillation, the 2012 ESC Focused Update Guidelines on Atrial Fibrillation, the 2012 ESC Guidelines on Heart Failure, and the 2014 NICE guidelines on AF. He was Deputy Editor (“content expert”) for the 9th ACCP guidelines on antithrombotic therapy for AF (2012). Professor Lip has acted as Senior Editor for major international textbooks [eg, Lip GYH, Hall JE (eds) Comprehensive Hypertension. Mosby] and Section Editor on hypertension (eg, Crawford, DiMarco, Paulus Cardiology, now in 3rd edition), as well as contributed to major textbooks [eg, the European Textbook of Cardiovascular Medicine (chapter on atrial fibrillation that serves as the core curriculum for ESC cardiology trainees), and Crawford’s Cardiology textbook chapter on atrial fibrillation, etc. Professor Lip is involved at the senior editorial level for major international journals, including Thrombosis & Haemostasis (Editor-in-Chief, Clinical Studies); Europace (Associate Editor); and Circulation (Guest Editor).
  • Dr. Jack Ansell is former Chair of Medicine, Lenox Hill Hospital and Professor of Medicine at Hofstra-North Shore/LIJ School of Medicine. He is a clinical investigator with a principal focus on the clinical problems of thrombosis, antithrombotic therapy, and the application of new modes of delivering and monitoring anticoagulants. Prior to his position in New York, Dr. Ansell was a Professor of Medicine and Vice Chairman of the Department of Medicine at Boston University School of Medicine. Dr. Ansell has helped to identify and provide an understanding of the problems related to the management of warfarin therapy and was one of the first investigators to identify and show that patients can manage their own therapy through home monitoring. He has been a leader in the promotion of high quality anticoagulation management through the development of anticoagulation clinics and was founder and president for over 15 years of the Anticoagulation Forum. Dr. Ansell has been the lead author for over 10 years of the major consensus guidelines for antithrombotic therapy through the American College of Chest Physicians Consensus Conference on Antithrombotic Therapy, and is lead editor of a one-of-a- kind textbook entitled Managing Oral Anticoagulation: Clinical and Operational Guidelines. Dr. Ansell has also held a leadership position in the National Blood Clot Alliance as past Chair of the Medical and Scientific Advisory Board. Dr. Ansell is a Master of the American College of Physicians and a Fellow of the American Heart Association. He received his medical degree from the University Of Virginia School Of Medicine and completed his medical residency at Tufts-New England Medical Center in Boston, followed by a fellowship in Hematology at Boston University and the Boston’s Veterans Administration Hospital.
    • Emergency Medicine
    • Thromboembolism
    • Atrial Fibrillation
    • Acute Coronary Syndrome
    • Venous Thromboembolism
    • Acute Heart Failure
    • Cardiovascular Emergency Medicine
    Associate Chair, Emergency Medicine, Baylor College of Medicine
    Associate Chair, Emergency Medicine, Baylor College of Medicine
    W. Frank Peacock IV, MD, FACEP is a Professor of Emergency Medicine, Associate Chair, and Research Director for Emergency Medicine at the Baylor College of Medicine, in Houston, Texas. He is currently on the Board of Directors, Chair of the publication committee, and has served as past President of the Society of Cardiovascular Patient Care (formerly known as the Society for Chest Pain Centers). With over 400 peer reviewed publications on heart failure and acute coronary syndromes, Dr. Peacock is also the co-editor of the textbooks Cardiac Emergencies, Short Stay Management of Heart Failure, and Short Stay Management of Chest Pain. He is the 2004 and 2010 winner of the Best Research Paper Award from the American College of Emergency Physicians, and is the Codman Award recipient from the American Association of Group Practice. Dr. Peacock has and continues to serve as PI or co-PI for many high profile national and international clinical trials such as PRONTO, ADHERE-EM, IMPACT, CHOPIN, CLUE, FASTTRACK, and TRUE-HF. Dr. Peacock’s research focus is that of cardiovascular emergency medicine, and includes acute coronary syndrome, acute heart failure, venous thromboembolic disease, atrial fibrillation, biomarkers, improvements in emergency medical care and more rapid patient disposition. Dr. Peacock received his medical degree from Wayne State University Medical School and completed his Emergency Medicine training at William Beaumont Hospital, Detroit, Michigan.
    • Internal Medicine
    • Interventional Cardiology
    • Cardiac Care Unit
    Director of the Cardiac Care Unit, Duke University Medical Center
    Director of the Cardiac Care Unit, Duke University Medical Center
    Dr. Christopher Granger is a Professor of Medicine in the Division of Cardiology at Duke University and Director of the Cardiac Care Unit for the Duke University Medical Center. Dr. Granger is a Fellow of the American College of Cardiology, the American Heart Association, and of the European Society of Cardiology. He is Associate Editor of the American Heart Journal and serves on the editorial board of the Journal of the American College of Cardiology. He is a cardiology section author for Current Medical Diagnosis and Treatment. He serves on the publication oversight committee of the American Heart Association and he is chairman of the Advisory Working Group of the American Heart Association Mission: Lifeline program. He is a member of the 2011 ACC/AHA STEMI Guidelines Committee. He has served on FDA advisory committees on an ad hoc basis. He is on the Board of External Experts of the National Heart, Lung and Blood Institute (NHLBI). Dr. Granger’s primary research interest is in the conduct and methodology of large randomized clinical trials in heart disease; he has co-authored more than 400 peer-reviewed manuscripts. He currently serves on a number of clinical trial steering committees and data safety monitoring committees. He has coordinated the Duke Clinical Research Institutes' activities in many clinical trials evaluating acute MI reperfusion and antithrombotic strategies in acute coronary syndromes and in atrial fibrillation. Dr. Granger is co-chairman of the Steering Committee of the ARISTOTLE trial assessing an oral factor Xa inhibitor for stroke prevention in atrial fibrillation. In addition, he is co-director of the Reperfusion of Acute MI in Carolina Emergency Departments (RACE) projects, North Carolina state-wide programs to improve reperfusion care for acute myocardial infarction and care for cardiac arrest.
    • Hematology
    Hematologist at Brigham and Women's Hospital and Dana Farber Cancer Institute
    Hematologist at Brigham and Women's Hospital and Dana Farber Cancer Institute
    Jean M Connors MD is a clinical hematologist at Brigham and Women’s Hospital and Dana Farber Cancer Institute, the Medical Director of the inpatient Hemostatic Antithrombotic Stewardship program and the outpatient Anticoagulation Management Services, and an assistant professor of medicine at Harvard Medical School. She attended Johns Hopkins School of Medicine, did medical residency at Beth Israel Hospital Boston, and completed fellowship training in hematology-oncology at Brigham and Women’s Hospital and in transfusion medicine at the Harvard Joint Program in Transfusion Medicine.
    • Interventional Cardiology
    Head of Atherothrombosis, Inflammation, and Platelets; University of Freiburg
    Head of Atherothrombosis, Inflammation, and Platelets; University of Freiburg
    • Associate Professor of Medicine, Interventional Cardiology at University of Freiburg
    Associate Prof. Dr. Ingo Ahrens is a clinician-researcher and interventional cardiologist at the Heart Center, University of Freiburg, Germany, where he holds the position as deputy chief and head of the chest pain unit. He is also head of the translational research group Atherothrombosis, Inflammation and Platelets. A main focus of the translational research of Dr. Ahrens is the development of novel therapeutic strategies for the treatment and prevention of atherothrombosis. On the clinical side, for many years Dr. Ahrens was involved in the development of novel parenteral anticoagulants in acute coronary syndromes and the late stage clinical development of non-Vitamin K antagonist oral anticoagulants (NOACS).
    Medical Education and Scientific Support at Boehringer Ingelheim
    Medical Education and Scientific Support at Boehringer Ingelheim
    • Senior Medical Advisor at Boehringer ingelheim
    Joanne is a scientist at Boehringer Ingelheim, based at their research site in southern Germany. She has been involved with medical and scientific education regarding dabigatran, including in collaborative efforts with many academic centers to further understand the role of thrombin inhibition in disease processes. She has played a key role in the research and development of idarucizumab, the specific reversal agent for dabigatran.
    • Cardiovascular Disease
    • Internal Medicine
    • Executive Vice President of Clinical and Medical Affairs at Perosphere
    Dr. Costin is Executive Vice President of Clinical and Medical Affairs at Perosphere, Inc. in Danbury, CT. Perosphere is pharmaceutical company that targets unmet medical needs in anticoagulation therapy. Currently, the company is developing both a reversal drug (ciraparantag) for the broad-spectrum reversal of all approved direct oral anticoagulants and heparins, as well as a new point of care coagulometer that measure intrinsic clotting potential as affected by all anticoagulants including warfarin. Prior to joining Perosphere, Dr. Costin was Corporate Vice President of Research and Development at a pharmaceutical company focused on anti-epileptic drugs as well as oncology products and before that at another pharmaceutical company focused on cardiovascular products. Prior to a pharmaceutical career, Dr. Costin was in academic medicine in cardiology.
    • Cardiovascular Disease
    • Interventional Cardiology
    Director of Cardiac Catheterization Laboratories & Interventional Cardiology Guthrie Health Services Professor of Medicine Rutgers New Jersey Medical School Professor of Medicine Upstate University of NY
    • Surgical Critical Care
    • General Surgery
    Bryan A. Cotton, MD, MPH is currently Professor in the Department of Surgery at the University of Texas Health Science Center in Houston. In addition, he is on Faculty at the Center for Translational Injury Research in Houston and is the Director of the Surgical Critical Care, Trauma Surgery and Acute Care Surgery Fellowships at UT-Houston. His clinical specialties are trauma surgery and surgical critical care. Dr. Cotton’s research focuses on identifying best resuscitation strategies for hemorrhagic shock, the early prediction of patients who will receive massive transfusion of blood and blood products and use of thrombelastography to guide resuscitation and correct coagulopathy following injury. Recently, he has also investigated how best to manage severe bleeding in patient’s taking newer oral anticoagulants. To these ends, he holds funding from the National Institute’s of Health, the State of Texas Emerging Technologies Fund and the Department of Defense. Dr. Cotton is a member of numerous societies, including the American Association for the Surgery of Trauma, The Society of University Surgeons, and the Southern Surgical Association. He is also a Fellow of the American College of Surgeons and the Royal College of Surgeons and Physicians-Glasgow.
    • Cardiovascular Disease
    • Cardiologist at Royal Brompton Hospital and Imperial College London
    Dr. Vassiliou is a cardiologist at the Royal Brompton & Harefield Foundation NHS Trust, London and Faculty at Imperial College London, UK. He specialises in cardiac risk prevention and the use of multimodality imaging in guiding personalised care.
    • Cardiovascular Disease
    • Interventional Cardiology
    • Director of the Institute of Cardiology at "G. d'Annunzio" University, Chieti
    Dr. De Caterina is Professor and Director of the Institute of Cardiology at the "G. d’Annunzio" University in Chieti, Italy. He splits his time equally between research and the clinic. Dr. De Caterina’s research is focused in thrombosis and atherosclerosis, with a recent emphasis on nutrigenetics and nutrigenomics. Dr. De Caterina also serves as President of the International Society on Nutrigenetics/Nutrigenomics and President of the Working Group on Atherosclerosis, Thrombosis and Vascular Biology of the Italian Federation of Cardiology. He has served as Vice-President of the European Society of Cardiology, in which he was Chair of the Council of Basic Cardiovascular Science and the Working Group on Thrombosis. He also served as a member of the ESC Committee for Practice Guidelines and the Congress Programme Committee.